gamida cell stock target price

According to 2 Wall Street analyst s that have issued a 1 year GMDA price target the average GMDA price target is 1200 with the highest GMDA stock price forecast at 1500 and the. Rooms Rankings Earnings Newsletters.


Greenlighting Gamida Cell Nasdaq Gmda Seeking Alpha

Real-time trade and investing ideas on Gamida Cell Ltd GMDA from the largest community of traders and investors.

. Stock price fell by -183 on the last day Monday 24th Oct 2022 from 164 to 161During the last trading day the stock fluctuated 915 from a day. What are analysts forecasts for Gamida Cell stock. In a report released today Jason Butler from JMP Securities reiterated a Buy rating on Gamida Cell GMDA - Research Report with a price target of 1700.

The average Gamida Cell stock forecast 2023 represents a -247 decrease from the last price of 173000001907349. Stock Price Forecast. The 4 analysts offering price forecasts for Gamida Cell have a median target of 1250 with a high estimate of 1500 and a.

The current analyst and expert consensus on Gamida Cell is Buy with 0 strong sell and 4 strong buy opinions. The 5 analysts offering 12-month price forecasts for Gamida Cell Ltd have a median target of 1500 with a high estimate of 2200 and a low estimate of 700. Based on short-term price targets offered by five analysts the average price target for Gamida Cell comes to 1360.

The highest analyst price target is 2200 the. Gamida Cell Ltd. GMDA was reported by Needham on Thursday September 29 2022.

To contextualize these metrics consider that out of all US stocks GAMIDA CELL LTDs average. The average price target for Gamida Cell is 1375. The current price Gamida Cell GMDA is trading at is 177 which is out of the analysts predicted range.

The latest price target for Gamida Cell NASDAQ. The analyst firm set a price target for 900. GAMIDA CELL LTDs variance in analysts estimates is lower than -67745 of all US stocks.

Browse analyst ratings and price targets on all stocks. The forecasts range from a low of 800 to a high of 2200. According to 12 stock analysts the average 12-month stock price forecast for Gamida Cell stock is 1428 which predicts an increase of 72543.

The current projected Gamida Cell target price consensus is 146 with 5 analyst. BOSTON November 10 2022--Gamida Cell Ltd. The Gamida Cell Ltd.

GMDA the leader in the development of NAM-enabled cell therapy candidates for patients with hematological and solid cancers and other serious. For Gamida Cell stock forecast for 2025 12 predictions are offered for. This is based on 4 Wall Streets Analysts 12-month price targets issued in the past 3 months.

GMDA the leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers. Piper Sandler Adjusts Gamida Cells Price Target to 7 From 8 Reiterates Overweight Rating.


Gamida Cell Company Profile Stock Performance Earnings Pitchbook


Fn002aih5fmmum


Gamida Cell Readies Stem Cell Transplant Therapy For Fda Submission But Seeks Strategic Partners Amid Staffing Cuts Fierce Biotech


Gamida Cell S Cell Therapy Treatment Gains Breakthrough Status


S002295x7 Graphic15 Jpg


Gamida Cell Ltd Possibility Of Big Move Gamida Cell Stock Forecast Gamida Cell Stock Target Youtube


Is Gamida Cell Ltd Gmda A Stock To Watch After Losing 0 00 This Week


Gamida Looks To Build Out Cell Therapy Infrastructure Bioprocess Insiderbioprocess International


Gmda Stock Price Forecast Should You Buy Gmda


Gamida Cell Ltd Gmda Stock Price News Quote History Yahoo Finance


Gamida Cell Stock Nasdaq Gmda Quotes And News Summary Benzinga


Gamida Cell Stock Nasdaq Gmda Quotes And News Summary Benzinga


Gamida Cell Stock Recapping A Tough Year Nasdaq Gmda Seeking Alpha


Greenlighting Gamida Cell Nasdaq Gmda Seeking Alpha


A Lymph Node Targeted Amphiphile Vaccine Induces Potent Cellular And Humoral Immunity To Sars Cov 2 Science Advances


Earnings Whisper Number For Gmda Gamida Cell


Gamida Cell Stock Nasdaq Gmda Quotes And News Summary Benzinga


How Many Gamida Cell Ltd Nasdaq Gmda Shares Do Institutions Own


Gamida Cell Stock Recapping A Tough Year Nasdaq Gmda Seeking Alpha

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel